Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom

被引:8
|
作者
Kon T. [1 ]
Nakagawa N. [1 ]
Yoshikawa F. [1 ,2 ]
Haba K. [1 ]
Kitagawa N. [1 ]
Izumi M. [1 ]
Kumazaki S. [1 ]
Ishida S. [1 ]
Aikawa R. [1 ,2 ]
机构
[1] Department of Internal Medicine, Kuwana West Medical Center, 416-1 Kitabessho, Kuwana, 511-0819, Mie
[2] Department of Internal Medicine, Kuwana South Medical Center, 1 Chome-32-1 Chuocho, Kuwana, 511-0068, Mie
关键词
Gastrointestinal bleeding; Immunoglobulin light-chain amyloidosis; Kappa immunoglobulin light chain; Submucosal hematoma;
D O I
10.1007/s12328-016-0664-5
中图分类号
学科分类号
摘要
Immunoglobulin light-chain (AL) amyloidosis is characterized by the deposition of insoluble fibrils composed of immunoglobulin light chains secreted by monoclonal plasma cells. Given the recent advances in the therapy of AL amyloidosis, it is important to diagnose this disease as early as possible. Herein, we describe the case of a 62-year-old man with hepatitis C virus (HCV)-related cirrhosis presenting with hematochezia. Colonoscopy showed multiple submucosal hematomas within the region ranging from the transverse colon to the sigmoid colon. Kappa immunoglobulin light-chain amyloid deposition was also detected. Bone marrow examination revealed a monoclonal abnormal plasma cell population. Thus, the patient was diagnosed with systemic immunoglobulin light-chain amyloidosis. The hematochezia was conservatively managed. However, because of liver failure caused by liver cirrhosis, the patient developed massive pleural effusion and died of respiratory failure. Postmortem examination revealed amyloid deposition in the esophagus, stomach, duodenum, ileum, descending colon, pancreas, heart, and lung. In these organs, amyloid deposition was limited to the vascular wall. We concluded that AL amyloidosis can present hematochezia arising from submucosal hematoma in the large colon before other systemic symptoms appear. © 2016, Japanese Society of Gastroenterology.
引用
收藏
页码:243 / 251
页数:8
相关论文
共 50 条
  • [31] An evaluation of current treatment options for immunoglobulin light-chain amyloidosis
    Sachchithanantham, Sajitha
    Wechalekar, Ashutosh D.
    Hawkins, Philip N.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (03): : 229 - 244
  • [32] Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light-chain amyloidosis
    Cohen, Oliver
    Rendas-Baum, Regina
    McCausland, Kristen
    Foard, Darren
    Manwani, Richa
    Ravichandran, Sriram
    Lachmann, Helen
    Mahmood, Shameem
    Wisniowski, Brendan
    Hawkins, Philip N.
    Gillmore, Julian
    Hsu, Kristen
    Rebello, Sabrina
    Wechalekar, Ashutosh
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (03) : 422 - 431
  • [33] Predictors of Early Relapse Following Initial Therapy for Systemic Immunoglobulin Light Chain Amyloidosis
    Tandon, Nidhi
    Sidana, Surbhi
    Gertz, Morie A.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Buadi, Francis K.
    Dingli, David
    Fonder, Amie
    Hayman, Suzanne R.
    Hobbs, Miriam
    Gonsalves, Wilson I.
    Kapoor, Prashant
    Hwa, Yi L.
    Kyle, Robert A.
    Leung, Nelson
    Go, Ronald S.
    Lust, John A.
    Russell, Stephen J.
    Zeldenrust, Steven R.
    Rajkumar, S. Vincent
    Kumar, Shaji
    [J]. BLOOD, 2016, 128 (22)
  • [34] ROLE OF IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF SYSTEMIC IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS: RESULTS IN A SERIES FROM A SINGLE INSTITUTION
    Fernandez de Larrea, C.
    Sole, M.
    Cibeira, M. T.
    Tovar, N.
    Rosinol, L.
    Elena, M.
    Arostegui, J. I.
    Yaguee, J.
    Blade, J.
    [J]. HAEMATOLOGICA, 2014, 99 : 376 - 376
  • [35] Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis
    Rezk, Tamer
    Salota, Rashim
    Gan, Jaslyn J.
    Lachmann, Helen J.
    Fontana, Marianna
    Siew, Keith
    Martinez-Naharro, Ana
    Guillotte, Christianne
    Bass, Paul
    Sachchithanantham, Sajitha
    Mahmood, Shameem
    Petrie, Aviva
    Whelan, Carol J.
    Pinney, Jennifer H.
    Dockrell, Mark
    Foard, Darren
    Lane, Thirusha
    Wechalekar, Ashutosh D.
    Hawkins, Philip N.
    Walsh, Stephen B.
    Gillmore, Julian D.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (06) : 1016 - 1023
  • [36] Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis
    Caccialanza, Riccardo
    Palladini, Giovanni
    Klersy, Catherine
    Cereda, Emanuele
    Bonardi, Chiara
    Cameletti, Barbara
    Montagna, Elisabetta
    Russo, Paola
    Foli, Andrea
    Milani, Paolo
    Lavatelli, Francesca
    Merlini, Giampaolo
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (03) : 399 - 406
  • [37] Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience
    Hernandez-Reyes, Jesus
    Galo-Hooker, Evelyn
    Ruiz-Delgado, Guillermo J.
    Ruiz-Argueelles, Guillermo J.
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2012, 64 (06): : 604 - 608
  • [38] Patient-Reported Outcomes in Systemic Light-Chain Amyloidosis
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Samaras, Christy J.
    Faiman, Beth M.
    Valent, Jason
    Majhail, Navneet S.
    [J]. BLOOD, 2018, 132
  • [39] Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis
    Riccardo Caccialanza
    Giovanni Palladini
    Catherine Klersy
    Emanuele Cereda
    Chiara Bonardi
    Barbara Cameletti
    Elisabetta Montagna
    Paola Russo
    Andrea Foli
    Paolo Milani
    Francesca Lavatelli
    Giampaolo Merlini
    [J]. Annals of Hematology, 2012, 91 : 399 - 406
  • [40] The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China
    Huang, Xiang-Hua
    Liu, Zhi-Hong
    [J]. KIDNEY DISEASES, 2016, 2 (01) : 1 - 9